Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery Vinod H Thourani, MD, William S Weintraub, MD, Joseph M Craver, MD, Ellis L Jones, MD, John Parker Gott, MD, W.Morris Brown, MD, John D Puskas, MD, Robert A Guyton, MD The Annals of Thoracic Surgery Volume 70, Issue 3, Pages 778-783 (September 2000) DOI: 10.1016/S0003-4975(00)01641-6
Fig 1 Survival for the entire population of patients undergoing primary isolated mitral valve replacement at Emory University Hospitals from 1980 to 1997. Group 1 = elective mitral valve replacement without concomitant coronary artery bypass surgery, group 2 = urgent/emergent mitral valve replacement without concomitant coronary artery bypass surgery, group 3 = elective mitral valve replacement with concomitant coronary artery bypass surgery, and group 4 = urgent/emergent mitral valve replacement with concomitant coronary artery bypass surgery. The Annals of Thoracic Surgery 2000 70, 778-783DOI: (10.1016/S0003-4975(00)01641-6)